In our previous study, we demonstrate that enforced overexpression of Her2 in breast cancer cells upregulates the expression of β2-AR at both mRNA and protein levels [3], raised questions as to how the expression of β2-AR is modulated by Her2 in breast cancer. This evidence concerns the gene ADRB2 and breast carcinoma.